Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL

Author(s):: Eefting, M.; Halkes, C.J.M.; Wreede, L.C. de (0000-0002-7667-9369); Pelt, C.M. van; Kersting, S.; Marijt, E.W.A.; Borne, P.A. von dem; Willemze, R. (0000-0001-9115-3106); Veelken, H.; Falkenburg, J.H.F.

Published: 2014
Publication type: Article / Letter to editor

alloSCTT-cell depletionALLdonor lymphocyte infusionDLI

Date issued: 2014-02-28
Language: English
Is part of: Bone Marrow Transplantation (2014), Vol. 49, no. 2, p. 287-291
hdl: 1887/104432
doi: 10.1038/bmt.2013.111